176 related articles for article (PubMed ID: 6311283)
41. Tumor necrosis factor alpha and epidermal growth factor regulation of collagenase and stromelysin in adult porcine articular chondrocytes.
Mitchell PG; Cheung HS
J Cell Physiol; 1991 Oct; 149(1):132-40. PubMed ID: 1658009
[TBL] [Abstract][Full Text] [Related]
42. Comparison of vertebrate collagenase and gelatinase using a new fluorogenic substrate peptide.
Stack MS; Gray RD
J Biol Chem; 1989 Mar; 264(8):4277-81. PubMed ID: 2538433
[TBL] [Abstract][Full Text] [Related]
43. [Effect of unsaponifiable extracts of avocado and soybean (Piasclédine) on the collagenolytic action of cultures of human rheumatoid synoviocytes and rabbit articular chondrocytes treated with interleukin-1].
Mauviel A; Loyau G; Pujol JP
Rev Rhum Mal Osteoartic; 1991 Apr; 58(4):241-5. PubMed ID: 1647544
[TBL] [Abstract][Full Text] [Related]
44. Messenger function of prostaglandins in cell to cell interactions and control of proteinase activity in the rheumatoid joint.
McGuire MK; Meats JE; Ebsworth NM; Murphy G; Reynolds JJ; Russell RG
Int J Immunopharmacol; 1982; 4(2):91-102. PubMed ID: 6284664
[TBL] [Abstract][Full Text] [Related]
45. Human osteoblasts in vitro secrete tissue inhibitor of metalloproteinases and gelatinase but not interstitial collagenase as major cellular products.
Rifas L; Halstead LR; Peck WA; Avioli LV; Welgus HG
J Clin Invest; 1989 Aug; 84(2):686-94. PubMed ID: 2547836
[TBL] [Abstract][Full Text] [Related]
46. The production in culture of metalloproteinases and an inhibitor by joint tissues from normal rabbits, and from rabbits with a model arthritis. I. Synovium.
Cambray GJ; Murphy G; Page-Thomas DP; Reynolds JJ
Rheumatol Int; 1981; 1(1):11-6. PubMed ID: 6287557
[TBL] [Abstract][Full Text] [Related]
47. Effects of 1-hydroxyethylidene-1,1 bisphosphonate and (chloro-4 phenyl) thiomethylene bisphosphonic acid (SR 41319) on the mononuclear cell factor-mediated release of neutral proteinases by articular chondrocytes and synovial cells.
Emonds-Alt X; Brelière JC; Roncucci R
Biochem Pharmacol; 1985 Nov; 34(22):4043-9. PubMed ID: 3933518
[TBL] [Abstract][Full Text] [Related]
48. Differential release of plasminogen activator and latent collagenase from mononuclear cell-stimulated synovial cells.
Golds EE; Ciosek CP; Hamilton JA
Arthritis Rheum; 1983 Jan; 26(1):15-21. PubMed ID: 6297507
[TBL] [Abstract][Full Text] [Related]
49. Interleukin-1 induces chondrocyte protease production: the development of collagenase inhibitors.
Pasternak RD; Hubbs SJ; Caccese RG; Marks RL; Conaty JM; DiPasquale G
Agents Actions; 1987 Aug; 21(3-4):328-30. PubMed ID: 2825481
[TBL] [Abstract][Full Text] [Related]
50. Endogenous activation of latent collagenase by rheumatoid synovial cells. Evidence for a role of plasminogen activator.
Werb Z; Mainardi CL; Vater CA; Harris ED
N Engl J Med; 1977 May; 296(18):1017-23. PubMed ID: 66627
[TBL] [Abstract][Full Text] [Related]
51. Purification of rabbit bone inhibitor of collagenase.
Cawston TE; Galloway WA; Mercer E; Murphy G; Reynolds JJ
Biochem J; 1981 Apr; 195(1):159-65. PubMed ID: 6272744
[TBL] [Abstract][Full Text] [Related]
52. Natural human monocyte gelatinase and its inhibitor.
Opdenakker G; Masure S; Proost P; Billiau A; van Damme J
FEBS Lett; 1991 Jun; 284(1):73-8. PubMed ID: 1647974
[TBL] [Abstract][Full Text] [Related]
53. Effects of all-trans-retinoic acid (retinoic acid) and 4-hydroxyphenylretinamide on synovial cells and articular cartilage.
Brinckerhoff CE; Nagase H; Nagel JE; Harris ED
J Am Acad Dermatol; 1982 Apr; 6(4 Pt 2 Suppl):591-602. PubMed ID: 6279710
[TBL] [Abstract][Full Text] [Related]
54. Potent collagenase inhibitors prevent interleukin-1-induced cartilage degradation in vitro.
Nixon JS; Bottomley KM; Broadhurst MJ; Brown PA; Johnson WH; Lawton G; Marley J; Sedgwick AD; Wilkinson SE
Int J Tissue React; 1991; 13(5):237-41. PubMed ID: 1666894
[TBL] [Abstract][Full Text] [Related]
55. Proteoglycan- and collagen-degrading enzymes from human interleukin 1-stimulated chondrocytes from several species: proteoglycanase and collagenase inhibitors as potentially new disease-modifying antiarthritic agents.
DiPasquale G; Caccese R; Pasternak R; Conaty J; Hubbs S; Perry K
Proc Soc Exp Biol Med; 1986 Nov; 183(2):262-7. PubMed ID: 3020566
[TBL] [Abstract][Full Text] [Related]
56. Intercellular messengers in joint tissues in rheumatoid arthritis. How disturbed control mechanisms may contribute to tissue destruction and repair.
Russell RG; McGuire MK; Meats JE; Ebsworth NM; Beresford J
Scand J Rheumatol Suppl; 1981; 40():75-87. PubMed ID: 6100920
[TBL] [Abstract][Full Text] [Related]
57. Effects of interleukin-1 and anti-inflammatory drugs on the degradation of human articular cartilage.
Shinmei M; Kikuchi T; Masuda K; Shimomura Y
Drugs; 1988; 35 Suppl 1():33-41. PubMed ID: 2834169
[TBL] [Abstract][Full Text] [Related]
58. Regulation of collagenase gene expression in synovial cells.
Brinckerhoff CE
J Rheumatol; 1987 May; 14 Spec No():61-3. PubMed ID: 3040994
[TBL] [Abstract][Full Text] [Related]
59. Characteristics of chondrocyte responses to a human interleukin 1-like factor.
Arend WP; Joslin FG; Massoni RJ
Clin Immunol Immunopathol; 1985 Sep; 36(3):358-70. PubMed ID: 2990784
[TBL] [Abstract][Full Text] [Related]
60. Differential regulation and expression of hyaluronan synthases in human articular chondrocytes, synovial cells and osteosarcoma cells.
Recklies AD; White C; Melching L; Roughley PJ
Biochem J; 2001 Feb; 354(Pt 1):17-24. PubMed ID: 11171074
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
